Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #37169
advertisement
Yang J
15
Showing records 1 to 15 |
Display all abstracts from
Yang J
98894
HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Kim Y
Translational vision science & technology
2022; 11: 30
98424
Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Yang N
Experimental Eye Research
2022; 215: 108915
98358
Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Yang J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2022; 145: 112472
98424
Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Yang J
Experimental Eye Research
2022; 215: 108915
98894
HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Yang J
Translational vision science & technology
2022; 11: 30
98358
Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Ouyang X; Fu H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2022; 145: 112472
98424
Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
He X
Experimental Eye Research
2022; 215: 108915
98894
HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Kim JY; Lee JM
Translational vision science & technology
2022; 11: 30
98424
Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Zhang W
Experimental Eye Research
2022; 215: 108915
98358
Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Hou X; Liu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2022; 145: 112472
98424
Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Xing Y
Experimental Eye Research
2022; 215: 108915
98894
HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Son WC
Translational vision science & technology
2022; 11: 30
98358
Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Xie Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2022; 145: 112472
98894
HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Moon BG
Translational vision science & technology
2022; 11: 30
98358
Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Yu H; Wang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2022; 145: 112472
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept